Roche to buy COVID test maker GenMark Diagnostics for $1.8 bn
RAPIDO: A new Spanish acronym to raise stroke awareness
15 March 2021Q&A: Children’s sleep habits
15 March 2021Roche to buy COVID test maker GenMark Diagnostics for $1.8 bn
Swiss pharma giant Roche said Monday it would pay $1.8 billion (1.5 billion euros) to buy US firm GenMark Diagnostics and thus broaden its rapid test portfolio, including for COVID-19.
